Moonlake Immunotherapeutics
MLTX
Revenue
0.00
0.000.00%
-Assets
544.88M
▼-19.24M▼-3.41%
3 Months ChangeLiabilities
14.85M
▲3.12M▲26.56%
3 Months ChangeFree Cash Flow
-15.16M
▼-6.14M▼-67.99%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-11
Form 8-K
ID: 0001213900-24-077513
2024-08-07
Form 10-Q
ID: 0001821586-24-000025
2024-08-07
Form 8-K
ID: 0001821586-24-000024
2024-06-10
Form 8-K
ID: 0001213900-24-051263
2024-06-06
Form 8-K
ID: 0001213900-24-050194
2024-05-07
Form 10-Q
ID: 0001821586-24-000020
2024-05-07
Form 8-K
ID: 0001821586-24-000019
2024-03-11
Form 8-K
ID: 0001213900-24-021233
2024-02-29
Form 8-K
ID: 0001821586-24-000007
2024-02-26
Form 8-K
ID: 0001213900-24-016737